Avinger to Announce Fourth Quarter and Full Year 2016 Results on March 6, 2017
22 February 2017 - 8:01AM
Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative
treatments for peripheral artery disease (“PAD”), today announced
that it will release its financial results for the fourth quarter
and full year 2016 after the close of trading on Monday, March 6,
2017. The Company will host a corresponding conference call
beginning at 1:30pm PT/4:30pm ET.
Individuals interested in listening to the conference call may
do so by dialing (844) 776-7820 for domestic callers or (661)
378-9536 for international callers and referencing Conference ID:
73906070. To listen to a live webcast, please visit the investor
relations section of Avinger's website at: www.avinger.com.
A replay of the call will be available beginning March 6, 2017
at 4:30pm PT/7:30pm ET through 4:30pm PT/7:30pm ET on March 7,
2017. To access the replay, dial (855) 859-2056 or (404) 537-3406
and reference Conference ID: 73863277. The webcast will also be
available on Avinger's website for one year following the
completion of the call.
About Avinger, Inc. Avinger, Inc. is a
commercial-stage medical device company that designs, manufactures
and sells image-guided, catheter-based systems for the treatment of
patients with peripheral artery disease (PAD). PAD is characterized
by a build-up of plaque in the arteries that supply blood to the
legs and feet. The company’s mission is to dramatically improve the
treatment of vascular disease through the introduction of products
based on its Lumivascular platform, the only intravascular
image-guided system of therapeutic catheters available in this
market. Avinger’s current Lumivascular products include the
Lightbox imaging console, the Ocelot family of catheters, which are
designed to penetrate total arterial blockages, known as chronic
total occlusions, or CTOs, and Pantheris, the first-ever
image-guided atherectomy device, designed to precisely remove
arterial plaque in PAD patients. For more information, please visit
www.avinger.com.
Investor Contact:
Matt Ferguson
Avinger, Inc.
(650) 241-7917
ir@avinger.com
Avinger (NASDAQ:AVGR)
Historical Stock Chart
From Apr 2024 to May 2024
Avinger (NASDAQ:AVGR)
Historical Stock Chart
From May 2023 to May 2024